Similar Posts
Letter Submitted to New England Journal of Medicine re ARDS Investigation
The April 3, 2003 New England Journal of Medicine (NEJM) issue contained an array of articles largely in support of a disputed multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), involving critically-ill, mentally incapacitated human beings with acute respiratory distress syndrome (ARDS) – who did not give their informed consent.
The accompanying editorial, "Controlling Research Trials," by Dr. J.M. Drazen, who serves on the NHLBI advisory committee that had approved the disputed trial, reveals much about the NIH attitude toward the rest of the world.
AHRP: Published NIMH Funded Prozac Trial Report Concealed Suicide Attempts by Teens
Recent revelations indicate that pharmaceutical companies have selectively reported partial (favorable) clinical trial results from pediatric antidepressant trials and concealed evidence of harm from physicians, other health care professionals, and the public. It is universally agreed in the literature that failure to disclose all trial results compromises physicians’ ability to provide professional care – thereby increasing the likelihood of causing preventable harm. More generally, failure to disclose trial results in scientific publications taints the scientific literature (by rendering it not credible) and, as New York State Attorney General Elliot Spitzer charged recently, constitutes plain and simple fraud.
AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine
When a federal judge ruled the vaccine to be an "investigational drug and a drug being used for an unapproved purpose" on December 22, 2003, FDA hurriedly issued a Final Rule for anthrax vaccine. The agency submitted its Final Rule just eight days after a federal court injunction, having failed to do so for 19 years. In a January 7, 2004 court hearing the same judge called FDA’s actions "highly suspicious." On October 27, 2004 FDA’s arbitrary and capricious promulgation of this Final Rule resulted in a permanent injunction, remanding the license to your agency to complete according to the law. The injunction also halted what the judge called DoD’s "illegal" mandatory anthrax vaccination program.
AHRP Speaks Out | Bias/Fraud | Business of Medicine | Concealed Data | Corporate-Corrupted Medicine | Corrupt Practices | Corrupt Public Health | Corrupted Science | Covid Pandemic | Current Controversies | Current Medical Atrocities | Global Public Health Institutions | Medical Research Ethics | Medical Safety Issues | Newsflash | Pharma Corrupt Influence | Unethical Experiments | Vaccine Controversies | Vaccine mandates | Vaccine RisksEndonuclease Fingerprint Indicates a Synthetic Origin of SARS-CoV-2
Endonuclease Fingerprint Indicates a Synthetic Origin of SARS-CoV-2 SARS-CoV-2 is the virus that caused the disease COVID-19. A detailed analysis of the evidence regarding the origin of the virus by a team of US and German forensic scientists led them to conclude that: “Both the restriction site fingerprint and the…
FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune
FDA Cut Off Critic’s Access to Drug Safety Database – Chicago Tribune Thu, 24 Feb 2005 The Chicago Tribune reports (below) about an eggregious example of the abuse of power by FDA officials who are retaliating against an independent scientist whose unique research project for detecting rare adverse drug reactions…
Japan Establishes Guidelines & Special Clinics to Treat HPV Vaccine Injuries
The following news report was submitted by Meryl Nass, MD, member of AHRP Board Vaccine injuries are real. They can be serious and often fail to respond to treatment. The most serious injuries are usually to the brain. Vaccine injuries may cause death. The US federal vaccine injury compensation program has paid…
